MedPath

Effect of oral l –carnitine and omega 3 supplementation separately and in combination on quality of life, quality of sleep, lipid profile and CRP in renal failure patients under hemodialysis _A randomized clinical trial

Phase 3
Conditions
Hemodialysis.
Encounter for adequacy testing for hemodialysis
Z49.31
Registration Number
IRCT20201027049166N1
Lead Sponsor
Yasouj University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
75
Inclusion Criteria

More than 18y s old
Hemodialysis more than twice in week for 3 month
Negative history of allergy to l carnitine and omega 3

Exclusion Criteria

Patients with requirement use of supplementation that intervention with lcarnitine or omega 3
Inpredictable drug complication
Patients do not cooperative
Patients with kidney transplantation plan
Patients can not continue study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Questionnare score of sleep quality. Timepoint: Before study-3month later. Method of measurement: Sleep quality Questionnare(PSQI).;Profile lipid. Timepoint: Before study-3month later. Method of measurement: Triglyceride, cholesterol kit.
Secondary Outcome Measures
NameTimeMethod
Questionnare score quality of life in hemodialysis. Timepoint: Before study-3month later. Method of measurement: Questionnare quality of life in hemodialysis pateint 1,3(KDQOL).
© Copyright 2025. All Rights Reserved by MedPath